What is MRSA?

European Respiratory Journal

Volumn 34, Issue 5, 2009, Pages 1190-1196

  Pantosti, A ^a   Venditti, M ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antibiotic resistance; Community acquired pneumonia; Methicillin resistant Staphylococcus aureus; Necrotising pneumonia; Nosocomial pneumonia; Staphylococcus aureus

Indexed keywords

PANTON VALENTINE LEUKOCIDIN;

BACTERIAL COLONIZATION; BACTERIAL STRAIN; COMMUNITY ACQUIRED PNEUMONIA; HEALTH CARE SYSTEM; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; COMMUNICABLE DISEASE CONTROL; CROSS INFECTION; EUROPE; EXOTOXINS; GENOTYPE; HOSPITALS; HUMANS; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PHENOTYPE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 71049118642     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00007709     Document Type: Review

References (87)

1. Wertheim H, Melles D, Vos M, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5: 751-762. (Pubitemid 41688980)
2. Biedenbach D, Moet G, Jones R. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis 2004; 50: 59-69.
3. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-317. (Pubitemid 39050477)
4. Hoban D, Biedenbach D, Mutnick A, et al. Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000). Diagn Microbiol Infect Dis 2003; 45: 279-285.
5. Lyon B, Skurray R. Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev 1987; 51: 88-134. (Pubitemid 17037066)
6. Jevons M. "Celbenin"-resistant staphylococci. Br Med J 1961; 1: 124.
7. Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2000; 44: 1549-1555. (Pubitemid 30340793)
8. Panlilio A, Culver D, Gaynes R, et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992; 13: 582-586.
9. Pantosti A, Sanchini A, Monaco M. Mechanisms of antibiotic resistance in Staphylococcus aureus. Future Microbiol 2007; 2: 323-334. (Pubitemid 47180928)
10. Hope R, Livermore DM, Brick G, et al. Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008; 62: Suppl. 2, ii65-ii74.
11. Chambers H. Treatment of infections and colonization caused by methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 1991; 12: 29-35.
12. Hiramatsu K, Hanaki H, Ino T, et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-136. (Pubitemid 27341646)
13. Tenover F, Biddle J, Lancaster M. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis 2001; 7: 327-332. (Pubitemid 32374355)
14. Liu C, Chambers H. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 2003; 47: 3040-3045. (Pubitemid 37229554)
15. Sievert DM, Rudrik JT, Patel JB, et al. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis 2008; 46: 668-674.
16. Tenover FC, Moellering RC Jr. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis 2007; 44: 1208-1215.
17. Stevens D. The role of vancomycin in the treatment paradigm. Clin Infect Dis 2006; 42: Suppl. 1, S51-S57.
18. Jones RN, Ross JE, Castanheira M, et al. United States resistance surveillance results for linezolid (LEADER Program for 2007). Diagn Microbiol Infect Dis 2008; 62: 416-426.
19. Peeters MJ, Sarria JC. Clinical characteristics of linezolid-resistant Staphylococcus aureus infections. Am J Med Sci 2005; 330: 102-104. (Pubitemid 41140465)
20. Marty FM, Yeh WW, Wennersten CB, et al. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. J Clin Microbiol 2006; 44: 595-597.
21. Murthy MH, Olson ME, Wickert RW, et al. Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate. J Med Microbiol 2008; 57: 1036-1038.
22. Faria NA, Carrico JA, Oliveira DC, et al. Analysis of typing methods for epidemiological surveillance of both methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. J Clin Microbiol 2008; 46: 136-144.
23. Chung M, de Lencastre H, Matthews P, et al. Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains. Microb Drug Resist 2000; 6: 189-198.
24. Shopsin B, Gomez M, Montgomery SO, et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 1999; 37: 3556-3563. (Pubitemid 29491091)
25. Milheirico C, Oliveira DC, de Lencastre H. Update to the multiplex PCR strategy for assignment of mec element types in Staphylococcus aureus. Antimicrob Agents Chemother 2007; 51: 3374-3377. (Pubitemid 350067556)
26. Enright MC, Robinson DA, Randle G, et al. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002; 99: 7687-7692. (Pubitemid 34568752)
27. Oliveira D, Tomasz A, de Lencastre H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002; 2: 180-189. (Pubitemid 34462453)
28. Varaldo P, Montanari M, Biavasco F, et al. Stafilococchi meticillino-resistenti: aspetti microbiologici e problemi connessi [Methicillin-resistant staphylococci: microbiological aspects and related issues]. Giornale Italiano delle Infezioni Ospedaliere 1994; 1: 105-110.
29. Speller DC, Johnson AP, James D, et al. Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet 1997; 350: 323-325.
30. National Nosocomial Infections Surveillance System, National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470-485.
31. Rubinstein E, Kollef MH, Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008; 46: Suppl. 5, S378-S385. (Pubitemid 351717325)
32. European Antimicrobial Resistance Surveillance System. EARSS Annual Report 2007. Available from: www.rivm.nl/earss/Images/EARSS%202007-FINAL-tcm61- 55933.pdf
33. Tiemersma EW, Bronzwaer SL, Lyytikainen O, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10: 1627-1634.
34. Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36: 53-59. (Pubitemid 36099097)
35. Shurland S, Zhan M, Bradham DD, et al. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin- susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 2007; 28: 273-279. (Pubitemid 46480725)
36. Zahar JR, Clec'h C, Tafflet M, et al. Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia?Clin Infect Dis 2005; 41: 1224-1231.
37. David MZ, Glikman D, Crawford SE, et al. What is community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis 2008; 197: 1235-1243.
38. King MD, Humphrey BJ, Wang YF, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006; 144: 309-317.
39. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290: 2976-2984. (Pubitemid 37505530)
40. Main CL, Jayaratne P, Haley A, et al. Outbreaks of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility. Can J Infect Dis Med Microbiol 2005; 16: 343-348. (Pubitemid 43089178)
41. Urth T, Juul G, Skov R, et al. Spread of a methicillin-resistant Staphylococcus aureus ST80-IV clone in a Danish community. Infect Control Hosp Epidemiol 2005; 26: 144-149. (Pubitemid 40445018)
42. Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005; 115: 642-648. (Pubitemid 43378904)
43. Adem PV, Montgomery CP, Husain AN, et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med 2005; 353: 1245-1251. (Pubitemid 41345946)
44. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352: 1445-1453. (Pubitemid 40471452)
45. Francis JS, Doherty MC, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005; 40: 100-107. (Pubitemid 40053465)
46. Centers for Disease Control and Prevention (CDC).: Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza - Louisiana and Georgia, December 2006-January 2007. Morb Mortal Wkly Rep 2007; 56: 325-329.
47. Higuchi W, Takano T, Teng LJ, et al. Structure and specific detection of staphylococcal cassette chromosome mec type VII. Biochem Biophys Res Commun 2008; 377: 752-756.
48. Tristan A, Bes M, Meugnier H, et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007; 13: 594-600.
49. Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab Invest 2007; 87: 3-9. (Pubitemid 44973648)
50. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29: 1128-1132. (Pubitemid 30265628)
51. Monaco M, Antonucci R, Palange P, et al. Methicillin-resistant Staphylococcus aureus necrotizing pneumonia. Emerg Infect Dis 2005; 11: 1647-1648. (Pubitemid 41384367)
52. Valentini P, Parisi G, Monaco M, et al. An uncommon presentation for a severe invasive infection due to methicillin-resistant Staphylococcus aureus clone USA300 in Italy: a case report. Ann Clin Microbiol Antimicrob 2008; 7: 11. (Pubitemid 351722550)
53. Etienne J. Panton-Valentine leukocidine: a marker of severity for Staphylococcus aureus infections? Clin Infect Dis 2005; 41: 591-593.
54. Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton Valentine leukocidin causes necrotizing pneumonia. Science 2007; 315: 1130-1133. (Pubitemid 46328024)
55. Bubeck Wardenburg J, Bae T, Otto M, et al. Poring over pores: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007; 13: 1405-1406. (Pubitemid 350224232)
56. Diep B, Carleton H, Chang R, et al. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis 2006; 193: 1495-1503. (Pubitemid 43794577)
57. Diep BA, Palazzolo-Ballance AM, Tattevin P, et al. Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS ONE 2008; 3: e3198.
58. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant Staphylococcus aureus infections among patients in the emergency department. N Engl J Med 2006; 355: 666-674. (Pubitemid 44244537)
59. Nguyen D, Bancroft E, Mascola L, et al. Risk factors for neonatal methicillin-resistant Staphylococcus aureus infection in a well-infant nursery. Infect Cont Hosp Epidemiol 2007; 28: 406-411. (Pubitemid 46658052)
60. Seybold U, Kourbatova E, Johnson J, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 genotype as a major cause of health care-associated bloodstream infections. Clin Infect Dis 2006; 42: 647-656. (Pubitemid 43271378)
61. Mody L, Kauffman CA, Donabedian S, et al. Epidemiology of Staphylococcus aureus colonization in nursing home residents. Clin Infect Dis 2008; 46: 1368-1373. (Pubitemid 351589935)
62. Del Giudice P, Blanc V, Durupt F, et al. Emergence of two populations of methicillin-resistant Staphylococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections. Br J Dermatol 2006; 154: 118-124. (Pubitemid 43381330)
63. Bartels M, Boye K, Larsen A, et al. Rapid increase of genetically-diverse methicillin-resistant Staphylococcus aureus, Copenhagen, Denmark. Emerg Infect Dis 2007; 13: 1533-1540. (Pubitemid 350006991)
64. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9: 978-984. (Pubitemid 36944519)
65. Witte W, Strommenger B, Cuny C, et al. Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006. J Antimicrob Chemother 2007; 60: 1258-1263. (Pubitemid 40179124)
66. Diep BA, Chambers HF, Graber CJ, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA 300 in men who have sex with men. Ann Intern Med 2008; 148: 249-257.
67. Witte W, Braulke C, Cuny C, et al. Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis 2005; 24: 1-5. (Pubitemid 40179124)
68. Gerogianni I, Mpatavanis G, Gourgoulianis K, et al. Combination of staphylococcal chromosome cassette SCCmec type V and Panton-Valentine leukocidin genes in a methicillin-resistant Staphylococcus aureus that caused necrotizing pneumonia in Greece. Diagn Microbiol Infect Dis 2006; 56: 213-216. (Pubitemid 44486636)
69. Scanvic A, Denic L, Gaillon S, et al. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis 2001; 32: 1393-1398. (Pubitemid 32424271)
70. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-797.
71. Scudeller L, Leoncini O, Boni S, et al. MRSA carriage: the relationship between community and healthcare setting. A study in an Italian hospital. J Hosp Infect 2000; 46: 222-229.
72. Drapeau CM, Angeletti C, Festa A, et al. Role of previous hospitalization in clinically-significant MRSA infection among HIV-infected inpatients: results of a case-control study. BMC Infect Dis 2007; 7: 36. (Pubitemid 46785006)
73. Miller R, Esmail H, Peto T, et al. Is MRSA admission bacteraemia community-acquired? A case control study. J Infect 2008; 56: 163-170.
74. Rollason J, Bastin L, Hilton AC, et al. Epidemiology of community-acquired meticillin-resistant Staphylococcus aureus obtained from the UK West Midlands region. J Hosp Infect 2008; 70: 314-320.
75. Carratala J, Garcia-Vidal C. What is healthcare-associated pneumonia and how is it managed? Curr Opin Infect Dis 2008; 21: 168-173.
76. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia: results froma large US database of culture-positive pneumonia. Chest 2005; 128: 3854-3862. (Pubitemid 43062645)
77. Venditti M, Falcone M, Corrao S, et al. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 2009; 150: 19-26.
78. Carratala J, Mykietiuk A, Fernandez-Sabe N, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007; 167: 1393-1399. (Pubitemid 47052438)
79. Morgan M. Methicillin-resistant Staphylococcus aureus and animals: zoonosis or humanosis?J Antimicrob Chemother 2008; 62: 1181-1187.
80. Strommenger B, Kehrenberg C, Kettlitz C, et al. Molecular characterization of methicillin-resistant Staphylococcus aureus strains from pet animals and their relationship to human isolates. J Antimicrob Chemother 2006; 57: 461-465. (Pubitemid 43240198)
81. de Neeling AJ, van den Broek MJ, Spalburg EC, et al. High prevalence of methicillin resistant Staphylococcus aureus in pigs. Vet Microbiol 2007; 122: 366-372. (Pubitemid 46756022)
82. Lewis HC, Molbak K, Reese C, et al. Pigs as source of methicillin-resistant Staphylococcus aureus CC398 infections in humans, Denmark. Emerg Infect Dis 2008; 14: 1383-1389.
83. Witte W, Strommenger B, Stanek C, et al. Methicillin-resistant Staphylococcus aureus ST398 in humans and animals, Central Europe. Emerg Infect Dis 2007; 13: 255-258. (Pubitemid 46193169)
84. Khanna T, Friendship R, Dewey C, et al. Methicillin resistant Staphylococcus aureus colonization in pigs and pig farmers. Vet Microbiol 2008; 128: 298-303. (Pubitemid 351305091)
85. Wulf MW, Sorum M, van Nes A, et al. Prevalence of methicillin-resistant Staphylococcus aureus among veterinarians: an international study. Clin Microbiol Infect 2008; 14: 29-34. (Pubitemid 350226567)
86. Pan A, Battisti A, Zoncada A, et al. Community-acquired methicillin-resistant Staphylococcus aureus ST398 infection, Italy. Emerg Infect Dis 2009; 15: 845-847.
87. Wulf M, Voss A. MRSA in livestock animals-an epidemic waiting to happen? Clin Microbiol Infect 2008; 14: 519-521.